Volume: December 2022, Issue 1

Dec 14, 2022 | Hot Topics

AARS Special Highlight

  • Please see recently published data from former AARS Grantee Dr. Alison Paine!

Industry News

  • Cutera’s AviClear now broadly available to US physicians and practitioners.

New Medical Research

  • Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.
  • Microneedling combined with botulinum toxin-A versus microneedling combined with platelet-rich plasma in treatment of atrophic acne scars: A comparative split face study.
  • Efficacy of microneedling with 35% glycolic acid peels versus microneedling with 15% trichloroacetic acid peels in treatment of atrophic acne scars: A randomized controlled trial.
  • Patient preferences for acne vulgaris treatment and barriers to care: A survey study.
  • Racial/ethnic variations in acne: A practical algorithm for treatment and maintenance, including skincare recommendations for skin of color patients with acne.
  • Value of high-frequency ultrasound in the treatment of moderate and severe acne vulgaris.
  • Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
  • A randomized split-face comparative study of long-pulsed alexandrite plus low-fluence Nd:YAG laser versus pulsed-dye laser in the treatment of rosacea.
  • Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne.
  • The relevant of sex hormone levels and acne grades in patients with acne vulgaris: A cross-sectional study in Beijing.
  • Oral zinc as a novel adjuvant and sparing therapy for systemic isotretinoin in acne vulgaris: A preliminary comparative study.
  • A split face comparative study to evaluate the efficacy of 40% pyruvic acid vs. microdermabrasion with 40% pyruvic acid on biomechanical skin parameters in the treatment of acne vulgaris.
  • Efficacy of diammonium glycyrrhizinate in the treatment of rosacea with papules and pustules: A randomized, double-blind, placebo-controlled study.
  • Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin.
  • Analysis of the epidemiological burden of acne vulgaris in China based on the data of global burden of disease 2019.

Clinical Reviews

  • Treatment strategies, including antibiotics, to target the immune component of rosacea.
  • Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series.
  • Utilization of light-emitting diodes for skin therapy: Systematic review and meta-analysis.
  • Use of patient-reported outcomes in acne vulgaris and rosacea clinical trials from 2011 to 2021: A systematic review.
  • Prevalence and demographics of truncal involvement among acne patients: Survey data and a review of the literature.
  • Minocycline-induced gum pigmentation during treatment for acne vulgaris.
  • Acne vulgaris, atopic dermatitis and rosacea: The role of the skin microbiota-A review.
  • Treatment and maintenance of cutaneous rosacea in Latino skin types with prescription medications and non-prescription cleansers and moisturizers as adjuncts: A review.
  • A rare case of acne medication-induced drug reaction with eosinophilia and systemic symptoms.

Related Posts

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: July 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...